Looking back at 25 years of advanced radiation treatment for tumors and other conditions
Reviews past advanced radiotherapy results and side effects in people treated at one hospital.
Plain-language title generated from the registry record
Registry title: Twenty-five Years of Advanced RadioTherapy at San Raffaele Hospital
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 90 years old?
Source: NCT07894900, who can take part
Where in Italy
- Department of Radiation Oncology, IRCCS San Raffaele Scientific InstituteMilan, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS San Raffaele
- Trial code
- NCT07894900
- Record updated
- 29 October 2026
- Original description
This retrospective observational study aims to evaluate the efficacy and toxicity of advanced radiotherapy (ART) techniques, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic radiotherapy (SRT), used at IRCCS Ospedale San Raffaele over the past 25 years and 5 months. The study includes treatments delivered using conventional fractionation, moderate hypofractionation, and ultra-hypofractionation. The primary endpoint is local control, defined as biochemical control in patients with prostate cancer.Read full original descriptionShow less
"Twenty-five Years of Advanced RadioTherapy (ART), With Intensity Modulation, Image-guidance, and Stereotactic Radiotherapy, With Classic Fractionation, Moderate- or Ultra-hypofractionation at San Raffaele Hospital "
This retrospective observational study aims to evaluate the efficacy and toxicity of advanced radiotherapy (ART) techniques, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic radiotherapy (SRT), used at IRCCS Ospedale San Raffaele over the past 25 years and 5 months. The study includes treatments delivered using conventional fractionation, moderate hypofractionation, and ultra-hypofractionation. The primary endpoint is local control, defined as biochemical control in patients with prostate cancer.
Inclusion: Patients with cancer; Patients with benign tumors/conditions; Treated with advanced radiotherapy techniques (IMRT, IGRT, SBRT, including Gamma Knife, CyberKnife, Tomotherapy, VMAT machines); Treated between January 2001 and May 2026.
Exclusion: Treated with 2D or 3D conformational radiotherapy,; Treated with palliative radiotherapy, not including an advanced radiotherapy technique; Patients with cancer; Treated before January 2001 or after May 2026.